CAMBRIDGE, England & BRISBANE, Calif.--(BUSINESS WIRE)-- Mogrify Ltd (Mogrify®), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell ...
UK cell therapy company Cell Mogrify has been awarded £420,000 funding from Innovate UK to accelerate its data-driven cell conversion programmes. The funding from the UK’s innovation agency will be ...
BioWorld - Thursday, November 20, 2025 See today's BioWorld Home » Mogrify lands $16M as it builds tech for converting one cell type to another To read the full story, subscribe or sign in.
Mogrify Limited (Mogrify ®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD ...
Cell Mogrify (Mogrify), has been granted funding by the UK’s innovation agency, Innovate UK, to accelerate regenerative cell therapies. United Kingdom-based company, Cell Mogrify (Mogrify), has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results